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Introduction: Cystic fibrosis (CF) is the most common life-limiting, recessively inherited
disease in the white population, associated with significantly high morbidity and mortality
rates; CF pulmonary disease, assessed by pulmonary function tests, arterial blood gases and
the Schwachman score, remains the most prevalent in terms of morbidity in the adult CF
population.
Objectives: The aim of the present study was to evaluate the relationship between resting
respiratory variables and exercise capacity in adult patients with CF.
Results: Study investigations undertaken in 18 CF patients and 11 healthy volunteers showed
that among the resting lung function parameters, inspiratory capacity (IC) at rest was the only
significant predictor of VO2 peak (rZ 0.67, p< 0.007) and VO2/t-slope (rZ 0.86, p< 0.0001).
The percentage of predicted FEV1 in adult CF patients was 77 33% pred. vs 104 16% pred. in
healthy subjects (p< 0.006); the corresponding percentage of IC at rest was 82 36% pred. in
patients vs 116 20% pred. in healthy (p< 0.003). CF patients presented with a significantly
prolonged rapid breathing after exercise (32br per minute at recovery for CF vs 22 for healthy;
p< 0.001), as well as a shortened inspiratory time.
Conclusion: Adult patients with CF show a limited exercise capacity with lower peak oxygen
consumption and prolonged oxygen kinetics. Interestingly, decreased IC qualified as the only
significant predictor of exercise capacity in our study.
ª 2010 Elsevier Ltd. All rights reserved.936537116.
hoo.com (G. Perpati).
0 Elsevier Ltd. All rights reserved.
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Figure 1 Rest inspiratory capacity (mean SE) in adult
patients with cystic fibrosis and healthy subjects.
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Cystic fibrosis (CF) is a progressive, life-limiting disease
with an autosomal recessive pattern of inheritance and
a significantly high incidence of 1:2000 to 1:3500 among
Caucasian populations.1,2 The advances in the therapeutic
management of CF over the years gradually led to a signif-
icant increase in life expectancy, accompanied by a corre-
sponding increase in the rate of CF patients surviving into
adulthood.3,4 Following the chronicity of the disease, CF
patients present a continuously increasing morbidity, with
the respiratory system being the most commonly affected
among the adult population.5,6 Indeed, the progressive
decline in lung function is considered to be the major
determinant of survival.7 Mucus plugging of small airways,
followed by bacterial infection causes chronic inflamma-
tory damage. Early radiological changes include hyperin-
flation and areas of atelectasis along with bronchiectasis in
the later stages of disease.8 As disease progresses, there is
flow limitation in large as well as small airways. In terminal
CF lung disease severe airway obstruction is the rule.9e12
Tidal expiratory flow limitation (EFL) has been associated
with chronic dynamic hyperinflation during tidal
breathing13 where end-expiratory lung volume is grater
than the relaxation volume of the respiratory system.
Furthermore it is known that EFL promotes dynamic
hyperinflation during exercise in COPD patients with
a consequent reduction in Inspiratory Capacity (IC), limiting
their exercise tolerance.14e16 Therefore, the exercise
capacity of patients with tidal EFL at rest should depend on
the magnitude of IC. CF pulmonary disease is assessed by
pulmonary function tests, arterial blood gases and
Schwachman score (SS).17 SS is a scoring system based on
general activity, physical findings, nutritional status and
chest radiography (Table 4). Patients with end-stage
pulmonary disease are considered as potential candidates
for lung transplantation. FEV1 30%, PaCO2> 50 mmHg and
PaO2< 55 mmHg are indications for lung transplantation
18
while VO2 max< 56% pred., poor 6 min walk performance,
pulmonary hypertension and body mass index (BMI)<
18 kg/m2 are additional considerations correlated with
worse prognosis. Maximal exercise capacity in CF is
reduced. Oxygen consumption during maximal exerciseTable 1 Baseline characteristics of the 18 CF and 11
healthy subjects.
Patients
with CF
Healthy
subjects
NZ 18 NZ 11
x sd x sd
Gender (M/F) 9/9 3/8
Age (years) 21 11 29 4
Schwachman score 74 11 e
BMI (body mass index) 19 3 24 3
FEV1 (% pred.) 77 33 104 16
FVC (% pred.) 95 30 106 15
FEV1/FVC (% pred.) 69 16 86 6
IC (ml) 2273 1010 2858 546
IC (% pred.) 82 36 116 20(VO2 peak) serves as a valuable monitoring tool for the
assessment of cardiorespiratory fitness level. Reduced
exercise ability correlates with prolonged oxygen kinetics
during maximal exercise and early recovery.19e21 The aim
of the present study was to investigate the relationship
between resting respiratory variables and exercise capacity
in adult patients with CF.Patients and methods
Patient population
18 patients with CF (9 male/9 female, aged 21 11y) and
11 healthy subjects (3 male/8 female, aged 29 4y) wereschwachman score
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Figure 2 Scatter graph of IC vs Schwachman score in adult
patients with cystic fibrosis.
Table 2 CPET indices at rest, peak exercise and recovery for both groups.
Patients Healthy subjects
Rest Peak Recovery Rest Peak Recovery
VE (lt/min) 12.5 2.4 57.2 19 14.4 6.7 11.3 2 81.3 13.2 20.5 5.8
VT (lt) 0.56 0.1 1.53 0.6 0.72 0.3 0.57 0.2 1.88 0.4 1.2 0.3
fb (breaths/min) 23 6 38 9 32 8 19 4 44 8 22 5
TI (s) 1.2 0.3 0.8 0.2 0.9 0.2 1.5 0.3 0.7 0.1 1 0.2
VT/TI (lt/s) 0.5 0.2 1.9 0.6 0.8 0.3 0.4 0.1 2.7 0.4 1.2 0.3
VO2 4.93 1.8 29.12 7 5.77 3.3 4.03 1.1 35.54 7.3 4.82 1.9
VD/VT 0.35 0.2 0.16 0.02 0.19 0.04 0.36 0.2 0.10 0.02 0.16 0.04
VE/VO2 25.65 5.5 19.9 5.88
VE/VCO2 28.51 5.3 26.62 3.14
VO2/t-slope 0.59 0.25 0.95 0.18
1446 G. Perpati et al.investigated. Anthropometric, clinical and resting pulmo-
nary function characteristics of both groups are listed in
Table 1. Both patients and healthy subjects underwent
pulmonary function test at rest and symptom-limited
treadmill cardiopulmonary exercise testing (CPET).
Pulmonary function tests
Measurements of FVC and FEV1 were obtained in the sitting
position using a closed-circuit spirometer (Vmax model 229;
SensorMedics; Yorba Linda, CA), as recommended by the
American Thoracic Society.22
Inspiratory capacity measurement
The procedure of inspiratory capacity (IC) measurement
was explained in detail to all participating subjects.
Patients were instructed to breathe normally, in the sitting
position, through a mouthpiece connected to a calibrated
pneumotachograph. Upon the achievement of steady tidal
volume (VT) and end-expiratory lung volume, a maximum
inspiration to total lung capacity (TLC) was performed. This
procedure was repeated four times. In all instances,oxygen consumption at peak exercise (ml/kg/min)
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Figure 3 Scatter graph of IC at rest vs VO2 peak in adult
patients with cystic fibrosis.subjects performed at least three satisfactory maneuvers,
two of which did not differ by >5%. The best IC was
selected. This approach has been previously demonstrated
to be reliable and reproducible.23
CPET
Each subject underwent a symptom-limited, incremental
CPET on a treadmill (Marquette Electronics 2000; Marquette
Electronics; Milwaukee, WI) on the same day as the
pulmonary function tests, utilizing the modified Naughton
protocol.24 All parameters were recorded in the upright
position before and during exercise and in the sitting
position for the first 10 min of recovery. A 12-lead ECG was
recorded every minute using the MAX 1 system. Blood
pressure (BP) measurements were obtained every 2 min
using a standard cuff-mercury sphygmomanometer. A pulse
oximeter was used for the monitoring of pulse oximetric
saturation. Baseline VO2 was calculated by averaging the
measurements obtained for 2 min before the onset of
exercise. VO2 peak was calculated as the average of
measurements obtained over the 20 s before thevo2/t slope at recovery
1,21,0,8,6,4,2
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Figure 4 Scatter graph of IC at rest vs VO2/t-slope in adult
patients with cystic fibrosis.
Resting respiratory variables and exercise capacity in patients 1447termination of the exercise. Anaerobic threshold was
determined using the V-slope technique16 and the result
was confirmed by a graph on which respiratory equivalents
for oxygen (VE/VO2) and carbon dioxide (VE/VCO2) were
plotted simultaneously against time. In order to evaluate
the oxygen consumption kinetics during recovery, the first
degree slope of VO2 for the first minute of recovery period
(VO2/t-slope) was calculated by linear regression using an
appropriate computerized statistical program.25 Patients
were encouraged to exercise scoring their sense of
exhaustion, leg fatigue and dyspnea using Borg scale.
Statistical analysis
Results are presented as means standard deviation (SD).
The unpaired Student’s t-test was used for the comparison
of CF patients against healthy subjects at rest. Analysis of
variance for repeated measures was used to compare
changes in CPET indices within and between subjects.
Correlations were tested by Pearson’s correlation coeffi-
cient. A multivariate linear regression analysis was used to
test the independent association of lung function with
oxygen kinetics (VO2 peak and VO2/t-slope), followed by
a stepwise regression analysis. A p value <0.05 was
considered statistically significant.
Results
Resting pulmonary function data are presented in Table 1.
FEV1 in patients was 77 33% pred vs 104 16% pred in
healthy subjects (p< 0.006) and IC at rest was 82 36%
pred in patients vs 116 20% pred in healthy (p< 0.003) or
2273 ml 1010 in patients vs 2857 ml 545 in healthy
(p< 0.046) (Fig. 1). IC was correlated with Schwachman
score (SS): rZ 0.55; p< 0.019; (Fig. 2). CPET indices at
rest, peak exercise and recovery for each group are pre-
sented in Table 2.
Patients’ ability to increase VT and VE was limited in
comparison with healthy subjects (from 0.56 to 1.53 lt vs
0.57 to 1.88 lt, p< 0.013 and 12.57 to 57.2 lt/min vs 11.3 to
81.3 lt/min, p< 0.001 respectively). CF patients showed
similar ability to increase breathing frequency from rest to
exercise in comparison with healthy subjects (23br per
minute to 38 vs 19 to 44; p< 0.098), however they exhibi-
ted a prolonged rapid breathing after exercise (32br per
minute at recovery for CF patients vs 22 for healthy
subjects; p< 0.001) along with shortened inspiratory time.
Mean peak oxygen uptake (VO2 peak) was
29.12 7.02 ml/kg/min in patients vs 35.54 7.31 in
healthy subjects; (p< 0.01) while VO2/t-slope at earlyTable 3 Significant correlations of VO2 peak and VO2/t-slope to
Parameters VO2 peak
r p v
FEV1, % pred 0.575 0.0
FVC, % pred 0.602 0.0
FEV1/FVC, % 0.513 0.0
IC, ml 0.608 0.0recovery was 0.59 0.25 in patients vs 0.95 0.18 in
healthy (p< 0.0001).
In a multivariate stepwise regression analysis, using peak
VO2 as the dependent variable and the pulmonary function
test measurements as independent variables respectively,
the only significant predictor emerged was IC (rZ 0.608;
p< 0.007). VO2/t-slope was also lower in CF patients
(0.59 0.25 vs 0.95 0.18; p< 0.0001) and showed signif-
icant correlation with IC (rZ 0.859; p< 0.0001). In a final
stepwise regression analysis including all independent
variables of the resting pulmonary function tests, the only
predictor selected for VO2 peak and VO2/t-slope was IC
(r2Z 0.37 for VO2 peak and 0.74 for VO2/t-slope) (Figs. 3
and 4).
The significant correlations of VO2 peak and VO2/t-slope
to resting lung function are listed in Table 3.
Discussion
Only a few trials have been performed to evaluate some
exercise variables in adult patients with cystic fibrosis. The
first time that exercise limitation in CF patients had been
correlated with pulmonary mechanics rather than circula-
tory factors and hypoxia was in 1971 (Godfrey et al).26 In
1990 Browning and coworkers investigating 11 adult
patients with CF showed that there was a correlation
between disease severity and respiratory rate during
exercise.27 Lands et al. (1992) in a study with 14 patients
found VE max and VO2 max decreased during exercise
without VE/VO2 and VE/VCO2 difference between patients
and healthy controls.28 In the same study VO2 max corre-
lated with FEV1. Nixon (1992) and Webb (1997) confirmed
that VO2 max was statistically significant prognostic index
for disease severity and survival.29,30 Pouliou et al. (2001)
describe dprolonged oxygen kinetics at early recovery in
adult patients with CF.20 The above mentioned trials
concluded exercise limitation in CF patients.
The main finding of this study indicates that in patients
with CF, IC at rest represents the only significant predictor
of VO2 peak and VO2/t-slope among the resting lung func-
tion parameters, according to multivariate stepwise
regression analysis. The decrease of IC observed in our
study was related to disease’s severity. Our results revealed
prolonged VO2 kinetics during early recovery. Both VO2/t-
slope and VO2 peak values were significantly lower in CF
patients in comparison with those of healthy subjects.
Furthermore, ventilatory response during exercise,
including a lot of parameters, is described, which was
altered at different stages of exercise. In CF patients there
is a limitation in ability to increase VE due to their lower VT.various resting respiratory parameters.
VO2/t-slope
alue r p value
13 0.774 0.0001
08 0.663 0.003
29 0.678 0.002
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1448 G. Perpati et al.In their effort to increase minute ventilation, an increase in
breathing frequency and shortened inspiratory time is
observed. This is well depicted at recovery which is
prolonged.
In CF patients there is a basic physiologic defect leading
to enlarged dead space and it is present even in the most
mildly affected patients. Progressive airway obstruction
reduces vital capacity resulting in VT limitation. In
compensation, decreased inspiratory time and increased
end-expiratory volume are observed in order to preserve
adequate inspiratory and expiratory flow rates.31,9 Airway
obstruction causes prolongation of expiratory flow rate and
in association with the increased breathing frequency
results in air trapping.27,32 The work and oxygen cost of
breathing are increased at high lung volumes and finally
exercise is discontinued.
Resting pulmonary function, VO2 peak and
VO2/t-slope
Although FEV1 (perc. pred.) has been reported as a good
indicator of exercise capacity in CF patients,28,30 our data
suggest that IC is the only independent predictor of VO2
peak and VO2/t-slope among all other respiratory variables
investigated. The role of IC as predictor of VO2 peak and
VO2/t-slope has not been previously investigated in
patients with cystic fibrosis.
Clinical implications
The finding that a simple, safe, non-invasive maneuver such
as the measurement of IC can predict exercise capacity
better than other respiratory parameters may prove to be
useful in clinical settings, either when CPET is not available
or when it is contraindicated.
Conclusion
In conclusion, the rest IC in adult patients with CF is the
only independent predictor of peak oxygen consumption
and prolonged oxygen uptake kinetics during exercise. It is
easy to measure and seems to be a useful index.Conflict of interest statement
The authors declare that no conflict of interests exists.
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